- Diseases of interest: breast, lung, pancreatic cancers, neurodegenerative diseases
- Platforms: proteomics, metabolomics, epigenomics, immunobiology, whole genome manipulation, gene-editing (CRISPR-Cas9 and shRNA), single-cell transcriptomics (scRNA-seq/snRNA-seq), transgenic and Cas9 mouse models of human diseases, cell imaging, protein, DNA and virus manipulations, high through-put screening strategies
- Pre-clinical trials, metronomic dosing, small animal imaging
- Innovation through technology development and refining
- Dissemination of new knowledge: peer-reviewed publications, invited plenary speaker, academic seminar speaker, public outreach
- Mentoring and training of future scientist and medical doctors. Leadership and career development
- Education of stakeholders: people with diseases, their families and friends, community and policy makers
- Resource acquisition and management